KCE REPORT 176S BREAST CANCER SCREENING WITH MAMMOGRAPHY FOR WOMEN IN THE AGE GROUP OF 70-74 YEARS APPENDIX 2012 www.kce.fgov.be KCE REPORT 176S GOOD CLINICAL PRACTICE BREAST CANCER SCREENING WITH MAMMOGRAPHY FOR WOMEN IN THE AGE GROUP OF 70-74 YEARS APPENDIX FRANÇOISE MAMBOURG, JO ROBAYS, SOPHIE GERKENS 2012 www.kce.fgov.be COLOPHON Title: Breast cancer screening with mammography for women in the age group of 70-74 years - Appendix Authors: Françoise Mambourg (KCE), Jo Robays (KCE), Sophie Gerkens (KCE) Reviewers: Frank Hulstaert (KCE), Pascale Jonckheer (KCE) External Experts: Marc Arbijn (WIV - ISP), Martine Berlière (UCL Saint-Luc), Hilde Bosmans (UZ Leuven), Jean-Benoit Burrion (ASBL Brummammo), Joëlle Desreux (CHU Liège), André-Robert Grivegnée (Institut Jules Bordet), Patrick Neven (UZ Leuven), Myriam Provost (SSMG), Hubert Thierens (UGent), Reinhilde Van Eeckhoudt (WVG), Anne Vandenbroucke (UCL Saint-Luc), Geert Villeirs (UZ Gent). External Validators: Philippe Autier (IPRI-Lyon), Geert Page (Jan Yperman Ziekenhuis), Chantal Van Ongeval (KU Leuven) Conflict of interest: None declared Layout: Ine Verhulst Disclaimer: • The external experts were consulted about a (preliminary) version of the scientific report. Their comments were discussed during meetings. They did not co-author the scientific report and did not necessarily agree with its content. • Subsequently, a (final) version was submitted to the validators. The validation of the report results from a consensus or a voting process between the validators. The validators did not co-author the scientific report and did not necessarily all three agree with its content. • Finally, this report has been approved by common assent by the Executive Board. • Only the KCE is responsible for errors or omissions that could persist. The policy recommendations are also under the full responsibility of the KCE. Publication date: 21 June 2012(2nd print; 1st print: 26 April 2012) Domain: Good Clinical Practice (GCP) MeSH: Breast Neoplasms ; Mammography ; Mass Screening NLM Classification: WP 870 - Breast - Neoplasms Language: English Format: Adobe® PDF™ (A4) Legal depot: D/2012/10.273/20 Copyright: KCE reports are published under a “by/nc/nd” Creative Commons Licence http://kce.fgov.be/content/about-copyrights-for-kce-reports How to refer to this document ? Mambourg F, Robays J, Gerkens S. Breast cancer screening with mammography for women in the age group of 70-74 years - Appendix. Good Clinical Practice (GCP). Brussels: Belgian Health Care Knowlegde Centre (KCE). 2012. KCE Report 176S. D/2012/10.273/20. This document is available on the website of the Belgian Health Care Knowledge Centre. KCE Report 176 Breast cancer screening 1 APPENDIX REPORT TABLE OF CONTENTS 1. REVIEW OF CLINICAL STUDIES ........................................................................................................ 3 1.1. PICO ...................................................................................................................................................... 3 1.2. SYSTEMATIC REVIEWS (SR) AND META-ANALYSES (MA) ............................................................. 3 1.2.1. Search for SR and MA ............................................................................................................ 3 1.3. RANDOMISED CONTROL TRIALS ...................................................................................................... 4 1.3.1. Search for RCTs ...................................................................................................................... 4 1.4. ADDITIONAL EVIDENCE ...................................................................................................................... 5 1.4.1. Diagnostic Errors ..................................................................................................................... 5 1.4.2. DCIS ........................................................................................................................................ 6 1.4.3. Overtreatment ......................................................................................................................... 7 1.4.4. Sojourn Time ........................................................................................................................... 7 1.5. QUALITY APPRAISAL .......................................................................................................................... 8 1.5.1. Systematic reviews and meta-analyses .................................................................................. 8 1.5.2. RCT ......................................................................................................................................... 8 1.6. DATA EXTRACTION TABLE .............................................................................................................. 10 1.6.1. Specific mortality reduction ................................................................................................... 10 1.6.2. All-cause mortality reduction ................................................................................................. 14 1.6.3. False positive and false negative mammography results ..................................................... 16 1.6.4. Over-diagnosis ...................................................................................................................... 17 1.6.5. DCIS ...................................................................................................................................... 19 1.6.6. Overtreatment ....................................................................................................................... 20 2. REVIEW OF MODELLING STUDIES ................................................................................................. 21 2.1. LITERATURE SEARCH STRATEGY .................................................................................................. 21 2.2. FLOW DIAGRAM ................................................................................................................................. 25 3. REVIEW OF QUALITY OF LIFE STUDIES ........................................................................................ 26 2 Breast cancer screening KCE Report 176 3.1. SEARCH STRATEGY ......................................................................................................................... 26 3.2. RESULTS OF THE SEARCH STRATEGY ......................................................................................... 29 3.3. SUMMARY OF SELECTED STUDIES ................................................................................................ 31 4. DECISION ANALYSIS ........................................................................................................................ 49 4.1. BREAST CANCER STAGE SPECIFIC RELATIVE SURVIVAL .......................................................... 49 5. REFERENCES .................................................................................................................................... 51 KCE Report 176 Breast cancer screening 3 1. REVIEW OF CLINICAL STUDIES Medline 1. meta-analysis.pt,ti,ab,sh. 21 (OVID): 2. 1 or (meta anal$ or metaanal$).ti,ab,sh. 1.1. PICO Filter 3. (methodol$ or systematic$ or Benefit SR or M-A quantitativ$).ti,ab,sh. • Patient: women between 70 and 74 years without breast cancer 4. ((methodol$ or systematic$ or symptom and without high risk of breast cancer quantitativ$) adj (review$ or overview$ or survey$)).ti,ab,sh. • Intervention: organized screening 5. (medline or embase or index • Comparison: usual care medicus).ti,ab. • Outcomes: mortality (all causes and specific), morbidity (mastectomy 6. ((pool$ or combined or combining) adj partial or complete) (data or trials or studies or results)).ti,ab. Harms 7. 6 or 4 or 3 or 5 • Patient: women between 70 and 74 years without breast cancer 8. 7 and review.pt,sh. symptom and without high risk of breast cancer 9. 8 or 2 • Intervention: organized screening 10. Case report.tw. • Comparison: usual care 11. Letter.pt. • Outcomes: diagnosis or therapeutics radiation side effects, additional 12. Historical article.pt. diagnosis tests, true positive, true negative, over diagnosis and over 13. Review of reported cases.pt. treatment. 14. Review,multicase.pt. 1.2. Systematic reviews (SR) and meta-analyses (MA) 15. or/10-14 A broad search of electronic databases (Medline, EMBASE, CDSR) was 16. 9 not 15 conducted in April 2011. 17. Breast/ or Breast Diseases/ 1.2.1. Search for SR and MA 18. Neoplasms/ Search Benefit and harms of mammography screening (70-74 y) 19. 17 and 18 questions 20. exp Breast Neoplasms/ Note Specific search for systematic reviews and meta-analysis 21. (breast$ adj5 neoplas$).tw. Update of KCE report 11 (search date 2004). 22. (breast$ adj5 cancer$).tw. Date 18/04/2011 on OVID Ovid MEDLINE(R) 23. (breast$ adj5 carcin$).tw. 24. (breast$ adj5 tumo$).tw. Keywords Breast neoplasms (MESH) and mass screening (or early 25. (breast$ adj5 metasta$).tw. detection) (MESH) and mammography (MESH) 4 Breast cancer screening KCE Report 176 26. (breast$ adj5 malig$).tw. 1.3. Randomised control trials 27. exp Carcinoma, Ductal, Breast/ A broad search of electronic databases (Medline, EMBASE,CCRT) was 28. 19 or 20 or 21 or 22 or 23 or 24 or 25 or conducted in April 2011. 26 or 27 1.3.1. Search for RCTs 29. mammography.mp. Search Benefit and harms of mammography screening (69-74 y) 30. Mammography/ questions 31. 29 or 30 Note Specific search for randomised